Design, Synthesis and Evaluation of Dihydro-1-indene Derivatives As Novel Tubulin Polymerisation Inhibitors with Anti-angiogenic and Antitumor Potency

Overview

Journal J Enzyme Inhib Med Chem

Specialty Biochemistry

Date 2023 Aug 17

PMID 37587873

Authors

Shengtao Xu

Yijun Sun

Peng Wang

Yuchen Tan

Lei Shi

Jian Chen

Affiliations

Soon will be listed here.

Abstract

Angiogenesis plays an important role in tumour generation and progression, which is used to supply nutrients and metastasis. Herein, a series of novel dihydro-1-indene derivatives were designed and evaluated as tubulin polymerisation inhibitors by binding to colchicine site, exhibiting anti-angiogenic activities against new vessel forming. Through structure-activity relationships study, compound was found to be the most potent derivative possessing the antiproliferative activity against four cancer lines with IC values among 0.028-0.087 M. Compound bound to colchicine site on tubulin and inhibited tubulin polymerisation . In addition, compound induced cell cycle arrest at G2/M phase, stimulated cell apoptosis, inhibited tumour metastasis and angiogenesis. Finally, the results of assay suggested that compound could prevent tumour generation, inhibit tumour proliferation and angiogenesis without obvious toxicity. Collectively, all these findings suggested that compound is a novel tubulin polymerisation inhibitor deserving further research.

References

Parupalli R, Akunuri R, Spandana A, Phanindranath R, Pyreddy S, Bazaz M . Synthesis and biological evaluation of 1-phenyl-4,6-dihydrobenzo[b]pyrazolo[3,4-d]azepin-5(1H)-one/thiones as anticancer agents. Bioorg Chem. 2023; 135:106478. DOI: 10.1016/j.bioorg.2023.106478. View

Tozer G, Kanthou C, Parkins C, Hill S . The biology of the combretastatins as tumour vascular targeting agents. Int J Exp Pathol. 2002; 83(1):21-38. PMC: 2517662. DOI: 10.1046/j.1365-2613.2002.00211.x. View

Zhu H, Sun H, Liu Y, Duan Y, Liu J, Yang X . Design, synthesis and biological evaluation of vinyl selenone derivatives as novel microtubule polymerization inhibitors. Eur J Med Chem. 2020; 207:112716. DOI: 10.1016/j.ejmech.2020.112716. View

Perez-Perez M, Priego E, Bueno O, Martins M, Canela M, Liekens S . Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth. J Med Chem. 2016; 59(19):8685-8711. DOI: 10.1021/acs.jmedchem.6b00463. View

Folkman J . Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2003; 29(6 Suppl 16):15-8. DOI: 10.1053/sonc.2002.37263. View

Galli U, Travelli C, Aprile S, Arrigoni E, Torretta S, Grosa G . Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents. J Med Chem. 2015; 58(3):1345-57. DOI: 10.1021/jm5016389. View

Li W, Sun H, Xu S, Zhu Z, Xu J . Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. Future Med Chem. 2017; 9(15):1765-1794. DOI: 10.4155/fmc-2017-0100. View

Peng X, Ren Y, Pan W, Liu J, Chen J . Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects. J Med Chem. 2022; 66(1):627-640. DOI: 10.1021/acs.jmedchem.2c01566. View

Li W, Sun H, Xu F, Shuai W, Liu J, Xu S . Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site. Bioorg Chem. 2019; 85:49-59. DOI: 10.1016/j.bioorg.2018.12.015. View

10.

Wang J, Miller D, Li W . Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective. Drug Discov Today. 2021; 27(3):759-776. PMC: 8901563. DOI: 10.1016/j.drudis.2021.12.001. View

11.

Muhlethaler T, Gioia D, Prota A, Sharpe M, Cavalli A, Steinmetz M . Comprehensive Analysis of Binding Sites in Tubulin. Angew Chem Int Ed Engl. 2021; 60(24):13331-13342. PMC: 8251789. DOI: 10.1002/anie.202100273. View

12.

Liu Z, Huang L, Zhou T, Chang X, Yang Y, Shi Y . A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers. J Biol Chem. 2022; 298(7):102063. PMC: 9218517. DOI: 10.1016/j.jbc.2022.102063. View

13.

Suhail Y, Cain M, Vanaja K, Kurywchak P, Levchenko A, Kalluri R . Systems Biology of Cancer Metastasis. Cell Syst. 2019; 9(2):109-127. PMC: 6716621. DOI: 10.1016/j.cels.2019.07.003. View

14.

Sun M, Zhang Y, Qin J, Ba M, Yao Y, Duan Y . Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization. Bioorg Chem. 2021; 113:104988. DOI: 10.1016/j.bioorg.2021.104988. View

15.

Huang W, Wu Y, Cheng D, He Z . Mechanism of epithelial‑mesenchymal transition inhibited by miR‑203 in non‑small cell lung cancer. Oncol Rep. 2020; 43(2):437-446. PMC: 6967097. DOI: 10.3892/or.2019.7433. View

16.

Chen J, Ahn S, Wang J, Lu Y, Dalton J, Miller D . Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents. J Med Chem. 2012; 55(16):7285-9. PMC: 3426659. DOI: 10.1021/jm300564b. View

17.

Mehlen P, Puisieux A . Metastasis: a question of life or death. Nat Rev Cancer. 2006; 6(6):449-58. DOI: 10.1038/nrc1886. View

18.

Mosca L, Ilari A, Fazi F, Assaraf Y, Colotti G . Taxanes in cancer treatment: Activity, chemoresistance and its overcoming. Drug Resist Updat. 2021; 54:100742. DOI: 10.1016/j.drup.2020.100742. View

19.

El-Naggar A, Hassan A, Elkaeed E, Alesawy M, Al-Karmalawy A . Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2. Bioorg Chem. 2022; 123:105770. DOI: 10.1016/j.bioorg.2022.105770. View

20.

Hu X, Li L, Zhang Q, Wang Q, Feng Z, Xu Y . Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site. Bioorg Chem. 2020; 97:103695. DOI: 10.1016/j.bioorg.2020.103695. View